Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 19944967)

Published in Neurosurg Clin N Am on January 01, 2010

Authors

Siddhartha Mitra1, Gordon Li, Griffith R Harsh

Author Affiliations

1: Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 200, Stanford, CA 94305, USA.

Articles citing this

Passive immunotherapeutic strategies for the treatment of malignant gliomas. Neurosurg Clin N Am (2012) 0.75

Articles by these authors

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20

NFKBIA deletion in glioblastomas. N Engl J Med (2010) 3.96

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest (2010) 3.74

A network model of a cooperative genetic landscape in brain tumors. JAMA (2009) 2.86

Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res (2005) 2.54

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol (2004) 2.21

High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res (2005) 2.10

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A (2011) 1.86

Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. JAMA (2009) 1.81

Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol (2005) 1.46

Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma. World Neurosurg (2012) 1.42

Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. J Mol Diagn (2005) 1.29

An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell (2010) 1.17

In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology (2002) 1.09

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III. Cancer Res (2013) 1.08

The incidence and significance of multiple lesions in glioblastoma. J Neurooncol (2013) 1.03

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. Expert Rev Vaccines (2012) 0.99

Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys (2011) 0.99

Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys (2012) 0.97

Development of an EGFRvIII specific recombinant antibody. BMC Biotechnol (2010) 0.97

Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Neurosurgery (2009) 0.97

Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. J Clin Invest (2014) 0.93

Radiosurgery for glomus jugulare: history and recent progress. Neurosurg Focus (2009) 0.91

National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus (2007) 0.91

Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT. Neurosurg Clin N Am (2012) 0.90

Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma. Case report. J Neurosurg (2002) 0.89

Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci (2013) 0.87

What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach. Int J Radiat Oncol Biol Phys (2012) 0.86

The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev (2012) 0.86

Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery. J Clin Neurosci (2012) 0.86

Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys (2013) 0.85

Synchronous subarachnoid drop metastases from a pituitary adenoma with multiple recurrences. Case report. J Neurosurg (2003) 0.85

Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy. Eur Spine J (2011) 0.84

Intracranial hypotension from intrathecal baclofen pump insertion. A case report and review of the literature. Stereotact Funct Neurosurg (2007) 0.84

Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases. Neurosurgery (2011) 0.84

Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery (2013) 0.83

Predictors of peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas. Neurosurgery (2008) 0.82

Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurgery (2010) 0.81

Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery (2003) 0.81

Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary (2007) 0.81

Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient. Clin Neuropathol (2015) 0.80

CyberKnife radiosurgery for the management of skull base and spinal chondrosarcomas. J Neurooncol (2013) 0.79

The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease. Pituitary (2011) 0.79

Cerebral perfusion imaging in vasospasm. Neurosurg Focus (2006) 0.79

Preoperative endovascular embolization of meningiomas: update on therapeutic options. Neurosurg Focus (2015) 0.79

Stereotactic radiosurgery of cranial nonvestibular schwannomas: results of single- and multisession radiosurgery. Neurosurgery (2011) 0.78

The invasive nature of glioblastoma. World Neurosurg (2011) 0.77

CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain. Neurosurg Focus (2007) 0.76

Anterior skull base surgery. Otolaryngol Clin North Am (2005) 0.76

Combining immunotherapy with radiation for the treatment of glioblastoma. J Neurooncol (2015) 0.76

Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations. Cerebrovasc Dis (2005) 0.75

A perspective on craniopharyngioma. World Neurosurg (2012) 0.75

Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions. Surg Neurol Int (2013) 0.75

Gene-protein correlation in single cells. Neuro Oncol (2011) 0.75

Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma. J Neurooncol (2015) 0.75

Perspectives on key articles in neurosurgery. Surg Neurol Int (2012) 0.75

Glioblastoma antigen discovery--foundations for immunotherapy. J Neurooncol (2015) 0.75

893 High-resolution Mapping of Human Glioma Genomes. Neurosurgery (2005) 0.75

The combined subtemporal-transfacial approach for the resection of juvenile nasopharyngeal angiofibromas with intracranial extension. Otol Neurotol (2015) 0.75

Inflammatory Pseudotumors of the Skull Base: Meta-Analysis. Otol Neurotol (2015) 0.75

Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT. Radiology (2016) 0.75

Endoscopic transtubular resection of a colloid cyst. Neurosciences (Riyadh) (2014) 0.75

Lanreotide promotes apoptosis and is not radioprotective in GH3 cells. Endocr Relat Cancer (2009) 0.75

Papillary tumor of the spinal cord: report of 2 cases. Am J Surg Pathol (2009) 0.75

Neurosurgery concepts. Surg Neurol Int (2011) 0.75

Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data. Int J Radiat Oncol Biol Phys (2003) 0.75

Concomitant ectatic posterior communicating artery and tentorial meningioma as a source of oculomotor palsy: case report. Neurosurgery (2005) 0.75